With 7% top-line growth and 8% bottom-line growth across the majority of its divisions, Abbott Labs reported a solid ...

Abbott Laboratories will make new investments ... “We are concerned that tariffs placed on medical and dental equipment threaten to disrupt the supply chain and raise costs for these critical ...

Abbott Laboratories (NYSE:ABT) recently received FDA approval for its Tendyne™ TMVR system, a significant milestone enhancing its cardiovascular product portfolio. Over the past month, Abbott's stock ...

Abbott Laboratories will make new investments ... “We are concerned that tariffs placed on medical and dental equipment threaten to disrupt the supply chain and raise costs for these critical ...

Abbott has invested nearly $5 billion in domestic manufacturing and equipment, plus another $10.7 billion in research and development. Abbott Chairman and CEO Robert Ford said in the call that the ...

“This furthers Abbott’s long history of investing in American innovation — in the past five years alone, the company has invested nearly $5 billion in manufacturing and equipment and $10.7 ...

R.D. Abbott's popular "Manufacturing with Silicone Rubber" workshop will make its return Aug. 26-29, with 2025 marking its ...

Like Johnson & Johnson did during its earnings call the day before, Abbott estimated that global tariffs would end up costing “a few hundred million dollars” in the latter half of this year ...

Procedures require the plant to contain leaks, fix equipment and test the area for pathogens, workers say. Leaks can become breeding grounds for bacteria. Abbott said “in a facility the size of ...

Abbott Laboratories will make new investments ... “We are concerned that tariffs placed on medical and dental equipment threaten to disrupt the supply chain and raise costs for these critical ...